GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bangkok Genomics Innovation PCL (BKK:BKGI) » Definitions » ROIC %

Bangkok Genomics Innovation PCL (BKK:BKGI) ROIC % : 47.61% (As of Mar. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Bangkok Genomics Innovation PCL ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Bangkok Genomics Innovation PCL's annualized return on invested capital (ROIC %) for the quarter that ended in Mar. 2023 was 47.61%.

As of today (2024-05-10), Bangkok Genomics Innovation PCL's WACC % is 10.36%. Bangkok Genomics Innovation PCL's ROIC % is 12.83% (calculated using TTM income statement data). Bangkok Genomics Innovation PCL generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Bangkok Genomics Innovation PCL ROIC % Historical Data

The historical data trend for Bangkok Genomics Innovation PCL's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bangkok Genomics Innovation PCL ROIC % Chart

Bangkok Genomics Innovation PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROIC %
- 26.70 126.88 61.21 27.80

Bangkok Genomics Innovation PCL Quarterly Data
Dec20 Dec21 Mar22 Dec22 Mar23 Dec23
ROIC % Get a 7-Day Free Trial - 101.79 - 47.61 -

Competitive Comparison of Bangkok Genomics Innovation PCL's ROIC %

For the Diagnostics & Research subindustry, Bangkok Genomics Innovation PCL's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bangkok Genomics Innovation PCL's ROIC % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bangkok Genomics Innovation PCL's ROIC % distribution charts can be found below:

* The bar in red indicates where Bangkok Genomics Innovation PCL's ROIC % falls into.



Bangkok Genomics Innovation PCL ROIC % Calculation

Bangkok Genomics Innovation PCL's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2023 is calculated as:

ROIC % (A: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2022 ) + Invested Capital (A: Dec. 2023 ))/ count )
=33.584 * ( 1 - -0.62% )/( (137.406 + 105.735)/ 2 )
=33.7922208/121.5705
=27.80 %

where

Invested Capital(A: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=293.021 - 21.381 - ( 165.905 - max(0, 35.563 - 212.078+165.905))
=105.735

Bangkok Genomics Innovation PCL's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Mar. 2023 is calculated as:

ROIC % (Q: Mar. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2022 ) + Invested Capital (Q: Mar. 2023 ))/ count )
=63.524 * ( 1 - -1.22% )/( (137.406 + 132.704)/ 2 )
=64.2989928/135.055
=47.61 %

where

Invested Capital(Q: Mar. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=298.477 - 18.228 - ( 147.545 - max(0, 27.114 - 209.263+147.545))
=132.704

Note: The Operating Income data used here is four times the quarterly (Mar. 2023) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bangkok Genomics Innovation PCL  (BKK:BKGI) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Bangkok Genomics Innovation PCL's WACC % is 10.36%. Bangkok Genomics Innovation PCL's ROIC % is 12.83% (calculated using TTM income statement data). Bangkok Genomics Innovation PCL generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases. Bangkok Genomics Innovation PCL earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Bangkok Genomics Innovation PCL ROIC % Related Terms

Thank you for viewing the detailed overview of Bangkok Genomics Innovation PCL's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bangkok Genomics Innovation PCL (BKK:BKGI) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
3689 Rama 4 Road, Phra Khanong Subdistrict, Khlong Toei Subdistrict, Bangkok, THA, 10110
Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products).

Bangkok Genomics Innovation PCL (BKK:BKGI) Headlines